Glycolic Acid in Skincare: Formulation Briefs, Sample Review and Claims Evidence for Brands
Quick answer
Glycolic acid is the smallest alpha hydroxy acid (AHA). In cosmetics it is used to exfoliate, meaning it helps shed the outermost layer of dead skin cells, and sometimes simply to adjust a product’s pH. FDA’s page on alpha hydroxy acids states that the extent of exfoliation depends on the type and concentration of the AHA, its pH and the other ingredients in the product.
That sentence is the core of any glycolic acid project. Before you ask a manufacturer for samples, settle four things:
- Product type and use occasion. A leave-on toner, a serum, a cream and a rinse-off cleanser keep the acid on skin for different lengths of time and are briefed differently.
- The numbers you will specify. Raw-material strength, glycolic acid content in the finished formula and final pH are three separate numbers. None of them replaces the others.
- Claim route per market. Specific appearance wording, such as “smoother-looking skin”, may be a cosmetic claim, but each line still has to be checked against its intended purpose, wording, evidence and destination market. FDA’s labeling claims page says claims to treat or prevent disease, or to affect the structure or function of the skin, make a US product a drug even if it also affects appearance.
- Sun-sensitivity labeling. In the United States, FDA recommends a sunburn alert on cosmetics containing AHAs. Check the equivalent requirement in every other destination market.
This guide is written for brand buyers, product managers and development teams. It covers glycolic acid alone. Our guide to salicylic acid in skincare covers the BHA side. For another AHA brief, see lactic acid in skincare, including its different roles and its relationship with sodium lactate.
What glycolic acid is, in brief
Glycolic acid (2-hydroxyacetic acid) has the formula C2H4O3 and a molecular weight of about 76, according to PubChem. It is very soluble in water. FDA’s labeling guidance for AHAs names glycolic acid and lactic acid as the predominant AHAs in cosmetic products.
FDA describes AHA-containing cosmetics being marketed for purposes such as smoothing fine lines and surface wrinkles, improving skin texture and tone, unblocking and cleansing pores, and improving skin condition in general. FDA also notes that some products have been marketed for treating acne, removing scars and lightening discolorations, and that products intended to treat or prevent disease, or to affect the structure or function of the body, are drugs. The same ingredient can therefore sit in a cosmetic or a drug. The product’s intended use, including its claims, decides which.
Section summary: Glycolic acid is a small, water-soluble AHA used for exfoliation and pH adjustment. Its effect depends on concentration, pH and the rest of the formula; its US legal category depends on intended use, including claims.
Define the product before the acid
Glycolic acid shows up in several cosmetic formats. Each one puts different weight on the same questions.
Swipe horizontally to view all columns →
| Format | Contact with skin | What a buyer usually judges on samples | Briefing questions specific to glycolic acid |
|---|---|---|---|
| Leave-on toner | Applied with a pad or hands, left on | Sting or tingle, residue, stickiness, pad wetness | Final pH target, how often it is used, what else in the routine contains acids |
| Leave-on serum or gel | Small dose, left on, often under other products | Tingle, tack, pilling under moisturizer or sunscreen | Acid content and pH stated per sample; thickener choice that tolerates a low pH |
| Leave-on cream or lotion | Larger dose, left on | Texture, after-feel, any sting on application | Emulsion stability at the target pH; packaging that limits air and contamination |
| Rinse-off cleanser | Short contact, then rinsed | Foam, cleansing feel, after-feel | Whether glycolic acid is there for exfoliation or only for pH; surfactant performance at that pH |
| Pads (pre-soaked) | Wiped on, left on | Pad saturation, drip, tingle | Liquid volume per pad, pad material, evaporation from the jar once opened |
Decide also who the product is for and how often they will use it. Daily evening use, two or three times a week, and “use alongside other actives” are different briefs. Write the intended schedule down, because it will shape the directions, the warnings and any tolerance evidence you commission.
Do not brief a “gentle” or “strong” glycolic acid product. Those are outcomes, not specifications. Brief the format, users and schedule, then judge the result on samples and evidence.
Section summary: Fix the format, users and use schedule first. A toner, serum, cream, cleanser and pad each raise different glycolic acid questions.
Three numbers that cannot replace each other
Glycolic acid briefs often go wrong when one number is used to stand in for another. Keep these three apart in every brief, sample record and specification.
1. Raw-material strength
Glycolic acid may be supplied as a solution rather than as the pure substance. A supplier’s grade is described by its own assay. If a formula sheet says “glycolic acid solution 10%”, that is 10% of the supplier’s material, not necessarily 10% glycolic acid. Ask for the grade code, the assay on the COA and the way the formula percentage is calculated.
2. Glycolic acid content in the finished formula
This is the amount of glycolic acid in the product, worked out from the raw-material assay and the formula. Some formulas also contain glycolate salts formed when part of the acid is neutralised. Ask the manufacturer to state the content as a glycolic acid equivalent calculated from the raw-material assay or specification, with the basis written out, for example “glycolic acid equivalent, % w/w, calculated from supplier assay, including any neutralised portion”. Keep that basis across all samples. This figure describes how much glycolic acid went into the formula. It is not the share of the acid that stays un-ionised at the final pH, and it is not an efficacy threshold.
3. Final pH of the finished product
pH decides how much of that glycolic acid equivalent is present as un-ionised acid and how much as glycolate. PubChem lists the pKa of glycolic acid as about 3.6 to 3.83. As the pH rises above that range, a growing share is present as glycolate. Two products with the same glycolic acid content but different pH values are therefore different products.
FDA’s AHA page reports the conditions under which the Cosmetic Ingredient Review (CIR) Expert Panel concluded that consumer products containing glycolic and lactic acid are safe: an AHA concentration of 10% or less, a final product pH of 3.5 or greater, and formulation or directions that address increased sun sensitivity. Two points about that statement matter for a brand:
- It is a CIR safety assessment cited by FDA, not a legal limit. FDA describes the CIR Expert Panel as the industry’s self-regulatory body and says the conclusion was based on industry-sponsored studies. It is not a rule in other markets either.
- It describes conditions that apply together. Content alone or pH alone does not tell you whether a product falls within them, and the specific product, its pH, how it is used and each destination market still need checking for each project.
Other markets have their own rules and may change them. Check the current legal text for each destination, not a summary or a competitor’s label.
Other formula factors
The same content and pH can still behave differently in a different base. FDA notes that earlier FDA studies found a cosmetic-type cream base caused an AHA to penetrate more deeply into skin than an AHA solution without the usual cosmetic ingredients. Buffering capacity, the other acids or actives present, humectants, solvents and the thickener system all shape how a product feels and performs. That is why a sample, not a spec sheet, is where formula decisions get tested.
Section summary: Raw-material strength, finished-formula content and final pH are different numbers. Record all three for each sample. Treat the CIR conditions as a CIR safety assessment cited by FDA, not a legal limit in the US or elsewhere.
Sun-sensitivity labeling and use directions
FDA’s AHA labeling guidance, issued in January 2005, recommends a “Sunburn Alert” on the labeling of cosmetics that contain an AHA and are applied to the skin or mucous membrane. In summary, the statement tells users that the AHA may increase sun sensitivity and the chance of sunburn, and advises sunscreen, protective clothing and limited sun exposure during use and for a week afterwards. The exact suggested wording is in the guidance. It is an FDA recommendation for the US, not a mandatory text that applies worldwide.
The guidance states that FDA guidances do not establish legally enforceable responsibilities and describe the agency’s current thinking. It also says it does not apply to products that contain an AHA as an incidental ingredient. For a brand selling in the US, the practical step is to decide with your regulatory advisor how the sunburn alert will appear, and to make sure your marketing does not contradict it.
The recommendation rests on human studies. In one FDA study by Kaidbey and colleagues, 29 subjects applied either 10% glycolic acid at pH 3.5 or a placebo for four weeks. Glycolic acid increased the skin’s sensitivity to UV light, and the effect was no longer evident one week after stopping. That is one study on one formula, but it explains why sun-protection directions are part of a glycolic acid brief.
Other markets set their own warning and labeling requirements for AHAs. Treat the US wording as one market’s recommendation.
Section summary: In the US, plan for a sunburn alert and consistent sun-protection directions. Confirm the warning requirements separately for each other market.
Packaging and stability questions specific to glycolic acid
An acidic water-based formula puts particular demands on its pack. Ask the manufacturer to address these points for your chosen components:
- Contact materials. Bottle, cap liner, dropper bulb, pump gasket and spring may all touch the product. Ask whether the formula has been used with these materials at your target pH, and what compatibility checks are proposed.
- pH and appearance over time. Track pH, colour, odour, clarity and viscosity in the final pack through stability work. A drift in pH changes the product.
- Viscosity over time. If a serum or gel thins or changes texture, ask the manufacturer to investigate before anyone settles on a cause. The formula, the packaging, the process and the storage conditions are all possibilities. Any fix needs a new coded sample.
- Pads and jars. For pre-soaked pads, check evaporation after opening, pad saturation at the bottom of the jar and whether the lid seals well.
- Preservation. Do not assume a low pH replaces preservation testing. Ask the manufacturer to confirm whether the final formula needs a preservative challenge test or other microbiological evidence, and how that will be done.
Our guides to cosmetic stability testing and packaging compatibility for pumps, droppers and airless packs explain what these studies involve.
Section summary: Plan compatibility, pH drift, viscosity and preservation checks for the final pack. A sample that looks right today does not show shelf-life behaviour.
Sample review: comparing glycolic acid versions
Most glycolic acid projects compare two or more versions that differ in content, pH or base. A useful sample review separates three things: what you can observe, what you can ask the manufacturer to explain or change, and what only formal evidence can answer.
The table below is an illustrative buyer example. It shows a one-week review of three leave-on toner versions, all in the same screw-cap bottle, applied with the same cotton pad and stored side by side under the same room conditions. The appearance and pack observations are made at the same one-week point. It is not real test data, not a client project and not a description of any GZ Cosmetics Lab formula.
Swipe horizontally to view all columns →
| Check | Toner G-01 (illustrative) | Toner G-02 (illustrative) | Toner G-03 (illustrative) | What this review cannot decide |
|---|---|---|---|---|
| Numbers on the sample sheet | Content and basis stated; measured pH stated | Content stated; no pH recorded | Content and pH stated; basis not stated | Whether the version meets each market’s rules |
| Appearance at one week | Clear, colourless | Clear | Slight haze | Behaviour over shelf life |
| Application feel (brand team) | Brief tingle, settles quickly | No tingle noted | Tingle noted by most of the team | Tolerance in target users |
| After-feel | Slightly tacky for a minute | Clean, no residue | Slight residue left on skin | Effect on the look of texture over weeks |
| Pack observation at one week | Cap thread clean | Some residue on cap thread | Cap thread clean | Compatibility with components over the stability period |
| Next request | Reduce tack; keep same basis | Record measured pH; explain residue | State basis; investigate haze; new code | Formal stability, compatibility, safety and claim work |
Rules that keep the record useful:
- Every version gets its own code. When the manufacturer revises a sample, it gets a new code. Do not overwrite the old record.
- Every version records the three numbers. Raw-material grade, finished-formula content with its basis, and measured pH with the date it was measured.
- Describe, then judge. Write “slight haze after one week at room conditions” before “not acceptable”.
- Compare like with like. Keep pack, applicator and storage the same across versions. A pad version or a different bottle is a separate branch with its own record, not a direct comparison with these toners.
- Keep team impressions in their place. A tingle noted by staff tells you about sensory fit. It is not tolerance evidence. Do not run informal patch tests on staff or friends and treat the results as data.
Section summary: Code every version, record content, basis and measured pH for each, and keep a column for what only formal work can show.
Claims evidence for a glycolic acid product
Glycolic acid has a long research history, and that history is a reason to consider it. It is not evidence for your product. The claim plan for each market should list the exact wording, the evidence it needs and the decision.
Swipe horizontally to view all columns →
| Claim idea | Typical evidence a brand should plan | Market gate |
|---|---|---|
| “Contains glycolic acid” / “with AHA” | Formula and raw-material documents | Factual; INCI name must match |
| “Exfoliates” / “helps remove dead surface skin cells” | Finished-product evidence suited to the wording | Check how each market treats exfoliation wording |
| “Smoother-looking skin” / “more even-looking texture” | Finished-product evidence for that appearance claim, for example an instrumental or expert-graded study scoped with a qualified provider | Appearance wording; keep it cosmetic |
| “Brighter-looking skin” / “radiance” | Finished-product evidence for the appearance claim | Avoid “lightening” or “removes discoloration” wording, which FDA lists among therapeutic uses |
| “Gentle”, “for daily use”, “for sensitive skin” | A study designed for the users and schedule you claim | Not a property of glycolic acid or of toners |
| “Treats acne”, “removes scars”, “peel” in a procedural sense | Exclude for a cosmetic | In the US, treatment claims make a product a drug |
FDA’s cosmetics labeling claims page says cosmetic labeling must be truthful and not misleading, that FDA has no list of approved cosmetic claims, and that the Federal Trade Commission regulates advertising claims. Apply the same claim set to your label, website, marketplace listings and creator briefs.
A note on the word “peel”. FDA describes some “skin peelers” as products that may contain relatively high concentrations of AHAs and are designed to remove the outer layer of the skin, and reports that the more serious adverse reactions appear to occur most often with the products that exfoliate most. Professional peels are outside the scope of this guide. For a retail cosmetic, keep “peel” off the claim list unless your regulatory review in each market has approved the exact wording and the evidence fits.
Our guides to cosmetic efficacy testing and claims compliance in the US, EU and China explain how claim studies are scoped.
Section summary: Match each claim’s exact wording to finished-product evidence and a market check. Exclude treatment and procedural peel language for a cosmetic.
Buyer’s sample evaluation and document request table
Use this table as the checklist that goes with your brief. The middle column says what to request. The right column records what you received.
Swipe horizontally to view all columns →
| Item | What to request from the manufacturer | Status |
|---|---|---|
| Raw material | INCI name, supplier grade code, COA with assay and lot number | Open / received |
| Formula content | Glycolic acid content with stated basis, per sample code | Open / received |
| Final pH | Target pH range and measured pH with date, per sample code | Open / received |
| Other acids or actives | Full list, so cumulative acid exposure in the routine can be reviewed | Open / received |
| Formula code | A unique code for each sample, used on all later documents | Open / received |
| Market check | Which destination-market rules were checked, against which current text, and by whom | Open / received |
| Labeling | Proposed warnings and directions per market, including sun-protection wording | Open / received |
| Packaging | Components proposed and the compatibility work recommended | Open / received |
| Stability | Parameters, conditions and duration proposed for the final formula in the final pack | Open / received |
| Preservation | How preservative performance will be confirmed | Open / received |
| Safety assessment | Who will prepare it for each market and what data it needs | Open / received |
| Claim support | Which claims the manufacturer thinks the formula could support, and which studies would be needed | Open / received |
| Commercial terms | MOQ, sample timing, production timing and what is included in the quote | Open / received |
Section summary: One checklist keeps raw material, content, pH, labeling, pack, stability, safety and claim items visible from the first sample to approval.
From brief to quote request
Send your brief with these questions:
- Which glycolic acid grade would you propose, and how will its assay and the finished-formula content be stated on each sample?
- What target pH range would you propose for this format and schedule, and how will measured pH be recorded?
- Which destination-market rules will the proposed content and pH be checked against?
- Which of our pack options has this type of formula been used with, and what compatibility work would you recommend?
- What is included in routine release testing, and what stability, preservative, safety and claim work would be scoped and quoted separately?
- What MOQ, sample timing and production timing apply once the formula and pack are settled?
If you want a glycolic-acid-only product, say so in your brief. If you are considering a multi-acid toner, list each acid and explain why it belongs in the formula. Acid choice, content, pH, testing scope, supply terms and claims must be confirmed for your project and destination markets. When your brief is ready, send it through our quote request form.
Key takeaways
- Glycolic acid is the smallest AHA. FDA says the extent of AHA exfoliation depends on acid type, concentration, pH and the other ingredients.
- Raw-material strength, finished-formula content and final pH are separate numbers. Record all three for every sample.
- The CIR conditions (10% or less, final pH 3.5 or greater, sun sensitivity addressed) are a CIR safety assessment cited by FDA, not a legal limit. Check the product, pH, use and each market’s current text.
- In the US, plan for a sunburn alert based on FDA’s AHA labeling guidance, and keep marketing consistent with it.
- Code every sample, describe before judging, and do not treat staff impressions as tolerance evidence.
- Treatment and procedural peel claims fall outside a cosmetic in the US. Appearance claims still need line-by-line review and finished-product evidence.
Frequently Asked Questions
What percentage of glycolic acid should we ask for? Ask the manufacturer for a proposed content and pH for your format, users, schedule and markets, with the basis for that proposal. A percentage without a pH and a stated basis does not define the product.
Is a lower pH always more effective? Do not brief it that way. pH changes how much of the acid is present as un-ionised acid, but effect and tolerability depend on the whole formula and how it is used. The CIR safety assessment cited by FDA also refers to a minimum final pH, and other markets may set their own conditions. Judge versions on samples and evidence.
Our sample sheet says “glycolic acid 10%”. Is that the formula content? Not necessarily. It may be 10% of a supplier solution. Ask for the raw-material assay and the content of glycolic acid in the finished formula on a stated basis.
Do we need a sunburn warning? In the US, FDA’s AHA labeling guidance recommends a sunburn alert for cosmetics containing AHAs, with an exception for incidental use. Other markets set their own requirements. Confirm the wording for each market with your regulatory advisor.
Can we call our glycolic acid toner gentle enough for daily use? Only with evidence for that formula, those users and that schedule. It is not a property of glycolic acid or of toners in general.
Why did our toner sample turn hazy or change pH? Record the sample code, date and storage conditions, and ask the manufacturer to investigate and send a revised sample under a new code. Shelf-life behaviour is answered by formal stability work on the final formula in the final pack.
Ready to Start Your Project?
Tell us your product requirements. Within 24 hours, our technical team will reply with a quotation or the questions needed to prepare one.